Global Health · NSE: MEDANTA · BSE: 543654
Q3 FY24 results · Oct–Dec 2023
Global Health reported revenue from operations of ₹832.60 crore (up 19.9% from Q3 FY23) and net profit of ₹123.54 crore (up 53.3% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 832.60 | 694.32 | +19.9% | 843.94 | −1.3% |
| Other income | 21.93 | 11.90 | +84.2% | 20.75 | +5.7% |
| Total income | 854.53 | 706.23 | +21.0% | 864.69 | −1.2% |
| Profit before tax | 172.36 | 112.45 | +53.3% | 170.60 | +1.0% |
| Net profit for the period | 123.54 | 80.61 | +53.3% | 125.16 | −1.3% |
| Attributable to shareholders of the company | 123.64 | — | — | — | — |
| EPS, basic (₹) | 4.61 | 3.08 | not comparable | 4.66 | −1.1% |
| Net margin (%) | 14.8 | 11.6 | 14.8 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 561.68 | 489.79 | +14.7% | 580.15 | −3.2% |
| Other income | 25.83 | 12.52 | +106.3% | 26.24 | −1.5% |
| Total income | 587.51 | 502.31 | +17.0% | 606.38 | −3.1% |
| Profit before tax | 120.87 | 79.89 | +51.3% | 126.89 | −4.7% |
| Net profit for the period | 87.34 | 58.77 | +48.6% | 95.10 | −8.2% |
| EPS, basic (₹) | 3.25 | 2.25 | not comparable | 3.54 | −8.2% |
| Net margin (%) | 15.6 | 12.0 | 16.4 |
Consolidated
- Filed with BSE
- 09 Feb 2024, 14:09 IST
- Board meeting
- 08 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Feb 2024, 14:09 IST
- Board meeting
- 08 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE